| Utility: PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 20 Feb 2020 | 1 Nov 2019 | 20 Feb 2020 |
| Utility: PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 20 Feb 2020 | 1 Nov 2019 | 20 Feb 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 20 Feb 2020 | 31 Oct 2019 | 20 Feb 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers Filling date: 9 Sep 2025 Issue date: 18 Feb 2020 | 6 Sep 2019 | 18 Feb 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 13 Feb 2020 | 30 Oct 2019 | 13 Feb 2020 |
| Utility: Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers Filling date: 9 Sep 2025 Issue date: 13 Feb 2020 | 2 Oct 2019 | 13 Feb 2020 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 9 Sep 2025 Issue date: 6 Feb 2020 | 21 Oct 2019 | 6 Feb 2020 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 9 Sep 2025 Issue date: 6 Feb 2020 | 21 Oct 2019 | 6 Feb 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 9 Sep 2025 Issue date: 6 Feb 2020 | 21 Oct 2019 | 6 Feb 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS Filling date: 9 Sep 2025 Issue date: 6 Feb 2020 | 2 Oct 2019 | 6 Feb 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 6 Feb 2020 | 26 Sep 2019 | 6 Feb 2020 |
| Utility: IMMUNOTHERAPY WITH B*07 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 6 Feb 2020 | 30 Jul 2019 | 6 Feb 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 9 Sep 2025 Issue date: 4 Feb 2020 | 23 Jul 2019 | 4 Feb 2020 |
| Utility: Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers Filling date: 9 Sep 2025 Issue date: 4 Feb 2020 | 28 Mar 2019 | 4 Feb 2020 |
| Utility: T cell receptors and immune therapy using the same Filling date: 9 Sep 2025 Issue date: 4 Feb 2020 | 15 Aug 2017 | 4 Feb 2020 |
| Utility: IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC Filling date: 9 Sep 2025 Issue date: 30 Jan 2020 | 11 Oct 2019 | 30 Jan 2020 |
| Utility: IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC Filling date: 9 Sep 2025 Issue date: 30 Jan 2020 | 11 Oct 2019 | 30 Jan 2020 |
| Utility: IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC Filling date: 9 Sep 2025 Issue date: 30 Jan 2020 | 11 Oct 2019 | 30 Jan 2020 |
| Utility: IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC Filling date: 9 Sep 2025 Issue date: 30 Jan 2020 | 11 Oct 2019 | 30 Jan 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS Filling date: 9 Sep 2025 Issue date: 30 Jan 2020 | 2 Oct 2019 | 30 Jan 2020 |
| Utility: Method for the absolute quantification of naturally processed HLA-restricted cancer peptides Filling date: 9 Sep 2025 Issue date: 28 Jan 2020 | 15 Dec 2015 | 28 Jan 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS Filling date: 9 Sep 2025 Issue date: 23 Jan 2020 | 2 Oct 2019 | 23 Jan 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 23 Jan 2020 | 2 Oct 2019 | 23 Jan 2020 |
| Utility: Transfected T-cells and T-cell receptors for use in immunotherapy against cancers Filling date: 9 Sep 2025 Issue date: 21 Jan 2020 | 16 Mar 2017 | 21 Jan 2020 |
| Utility: Transfected T-cells and T-cell receptors for use in immunotherapy against cancers Filling date: 9 Sep 2025 Issue date: 21 Jan 2020 | 16 Mar 2017 | 21 Jan 2020 |
| Utility: IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC Filling date: 9 Sep 2025 Issue date: 16 Jan 2020 | 25 Sep 2019 | 16 Jan 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers Filling date: 9 Sep 2025 Issue date: 14 Jan 2020 | 10 Jul 2019 | 14 Jan 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 14 Jan 2020 | 21 Feb 2019 | 14 Jan 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 9 Jan 2020 | 25 Sep 2019 | 9 Jan 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 9 Jan 2020 | 25 Sep 2019 | 9 Jan 2020 |
| Utility: NOVEL PEPTIDES, COMBINATION OF PEPTIDES AS TARGETS AND FOR USE IN IMMUNOTHERAPY AGAINST GALLBLADDER CANCER AND CHOLANGIOCARCINOMA AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 9 Jan 2020 | 6 Sep 2019 | 9 Jan 2020 |
| Utility: Peptides and combinations of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 9 Sep 2025 Issue date: 7 Jan 2020 | 23 Jul 2019 | 7 Jan 2020 |
| Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Filling date: 9 Sep 2025 Issue date: 7 Jan 2020 | 23 May 2019 | 7 Jan 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various cancers Filling date: 9 Sep 2025 Issue date: 7 Jan 2020 | 10 May 2019 | 7 Jan 2020 |
| Utility: Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) Filling date: 9 Sep 2025 Issue date: 7 Jan 2020 | 29 Mar 2019 | 7 Jan 2020 |
| Utility: T cell receptors and immune therapy using the same Filling date: 9 Sep 2025 Issue date: 7 Jan 2020 | 13 Jul 2018 | 7 Jan 2020 |
| Utility: Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers Filling date: 9 Sep 2025 Issue date: 7 Jan 2020 | 17 May 2018 | 7 Jan 2020 |
| Utility: T cell receptors and immune therapy using the same Filling date: 9 Sep 2025 Issue date: 7 Jan 2020 | 7 Dec 2017 | 7 Jan 2020 |
| Utility: Peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers Filling date: 9 Sep 2025 Issue date: 7 Jan 2020 | 4 May 2016 | 7 Jan 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 2 Jan 2020 | 30 Aug 2019 | 2 Jan 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 2 Jan 2020 | 30 Aug 2019 | 2 Jan 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 2 Jan 2020 | 30 Aug 2019 | 2 Jan 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS Filling date: 9 Sep 2025 Issue date: 2 Jan 2020 | 28 Aug 2019 | 2 Jan 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 2 Jan 2020 | 10 Jul 2019 | 2 Jan 2020 |
| Utility: A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 2 Jan 2020 | 19 Jun 2019 | 2 Jan 2020 |
| Utility: Novel peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Filling date: 9 Sep 2025 Issue date: 2 Jan 2020 | 24 May 2019 | 2 Jan 2020 |
| Utility: A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 9 Sep 2025 Issue date: 2 Jan 2020 | 9 Jul 2018 | 2 Jan 2020 |
| Utility: Immunotherapy against melanoma and other cancers Filling date: 9 Sep 2025 Issue date: 31 Dec 2019 | 5 Jul 2019 | 31 Dec 2019 |
| Utility: RELAXIN1 derived peptides for use in immunotherapy against various tumors Filling date: 9 Sep 2025 Issue date: 31 Dec 2019 | 10 May 2018 | 31 Dec 2019 |
| Utility: NOVEL PEPTIDES, COMBINATION OF PEPTIDES AS TARGETS AND FOR USE IN IMMUNOTHERAPY AGAINST GALLBLADDER CANCER AND CHOLANGIOCARCINOMA AND OTHER CANCERS Filling date: 9 Sep 2025 Issue date: 26 Dec 2019 | 6 Sep 2019 | 26 Dec 2019 |
